Skip to content

13F-HR filed by JW Asset Management, LLC

JW Asset Management, LLC filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-13, with 29 holding rows worth $136,522,000.

Accession
0001420506-17-000765
Filed
2017-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 29 entries on the cover page, a total value of $136,522,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $136,522,000 with VALUE read as thousands by filing date, 13F file number 028-16404. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
EAGLE PHARMACEUTICALS INC269796108COM525,755$31,356,000thousands by filing date
TESLA INC88160R901CALL67,225$22,930,000thousands by filing date
Amazon.com, Inc023135106COM18,287$17,580,000thousands by filing date
META PLATFORMS INC CL A30303M102COM55,000$8,304,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH70,000$6,060,000thousands by filing date
ANTARES PHARMA INC036642106COM1,671,956$5,417,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO444,439$4,667,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS25,000$4,318,000thousands by filing date
Microsoft Corp594918104COM53,000$3,948,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS270,775$3,433,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM73,649$3,426,000thousands by filing date
CAMBREX CORP132011107COM50,519$2,779,000thousands by filing date
CHIPOTLEMEXICANGRILLI169656105STOK9,000$2,770,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW315,980$2,221,000thousands by filing date
JUNIPER PHARMACEUTICALS INC COM48203L107Stock426,903$2,156,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM2,000$2,092,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH5,828$1,944,000thousands by filing date
CUMBERLAND PHARMACEUTICALS I230770109COM263,881$1,863,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW13,401$1,825,000thousands by filing date
Micron Technology,Inc.595112103COM41,000$1,613,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM29,722$1,560,000thousands by filing date
ALIMERA SCIENCES INC016259103COM966,000$1,304,000thousands by filing date
ARALEZ PHARMACEUTICALS INC03852X100COM289,664$663,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock178,654$652,000thousands by filing date
PETIQ INC71639T106COMMON STOCK20,000$542,000thousands by filing date
SONOMA PHARMACEUTICALS INC83558L105COM100,951$527,000thousands by filing date
DIGIRAD CORP253827109COM118,046$407,000thousands by filing date
TELIGENT INC NEW87960W104COM13,820$93,000thousands by filing date
INSYS THERAPEUTICS INC45824V209COMMON STOCK29,409$72,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-17-000765this filing2017-11-13acceptance time not in the bulk data set